Skip to main content
OpenTrials

Clinical trial condition

Tumor Virus Infections

Explore clinical trials studying Tumor Virus Infections. Study availability and eligibility vary by location and protocol.

1,486 public trials 253 recruiting studies
Refine in advanced search Browse all conditions

Tumor Virus Infections trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

NCT06041061

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations
  • Guangxi Center for Disease Control and Prevention Nanning, Guangxi, China
  • Henan Center for Disease Control and Prevention Zhengzhou, Henan, China
  • Shanxi Center for Disease Control and Prevention Taiyuan, Shanxi, China
  • Sichuan Center for Disease Control and Prevention Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

NCT03962465

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Virginia Charlottesville, Virginia, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

NCT05314023

Conditions
Communicable Diseases, Condylomata Acuminata, DNA Virus Infections, +17 more
Locations
  • Liucheng County Centers for Disease Control and Prevention ( Site 0005) Liuzhou, Guangxi, China
  • Center for Disease Control and Prevention of Rong An ( Site 0006) Liuzhou, Guangxi, China
  • Loudi Public Health Hospital (Loudi Occupational Disease Prevention And Treatment Hospital) ( Site 0 Louxing District, Hunan, China
  • Yuechi Disease Prevention and Control Center ( Site 0002) Guang’an, Sichuan, China
View Trial Details

Related conditions